BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25863679)

  • 1. Evidence for cholesterol-lowering activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation.
    Zanotti I; Turroni F; Piemontese A; Mancabelli L; Milani C; Viappiani A; Prevedini G; Sanchez B; Margolles A; Elviri L; Franco B; van Sinderen D; Ventura M
    Appl Microbiol Biotechnol; 2015 Aug; 99(16):6813-29. PubMed ID: 25863679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into teichoic acid biosynthesis by Bifidobacterium bifidum PRL2010.
    Colagiorgi A; Turroni F; Mancabelli L; Serafini F; Secchi A; van Sinderen D; Ventura M
    FEMS Microbiol Lett; 2015 Sep; 362(17):fnv141. PubMed ID: 26296705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kefir fermented milk and kefiran promote growth of Bifidobacterium bifidum PRL2010 and modulate its gene expression.
    Serafini F; Turroni F; Ruas-Madiedo P; Lugli GA; Milani C; Duranti S; Zamboni N; Bottacini F; van Sinderen D; Margolles A; Ventura M
    Int J Food Microbiol; 2014 May; 178():50-9. PubMed ID: 24667318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium.
    Egan M; Motherway MO; Kilcoyne M; Kane M; Joshi L; Ventura M; van Sinderen D
    BMC Microbiol; 2014 Nov; 14():282. PubMed ID: 25420416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient and reproducible method for transformation of genetically recalcitrant bifidobacteria.
    Serafini F; Turroni F; Guglielmetti S; Gioiosa L; Foroni E; Sanghez V; Bartolomucci A; Motherway MO; Palanza P; van Sinderen D; Ventura M
    FEMS Microbiol Lett; 2012 Aug; 333(2):146-52. PubMed ID: 22640171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering bifidobacterial-mediated metabolic interactions and their impact on gut microbiota by a multi-omics approach.
    Turroni F; Milani C; Duranti S; Mancabelli L; Mangifesta M; Viappiani A; Lugli GA; Ferrario C; Gioiosa L; Ferrarini A; Li J; Palanza P; Delledonne M; van Sinderen D; Ventura M
    ISME J; 2016 Jul; 10(7):1656-68. PubMed ID: 26859770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from genomes of representatives of the human gut commensal Bifidobacterium bifidum.
    Duranti S; Milani C; Lugli GA; Turroni F; Mancabelli L; Sanchez B; Ferrario C; Viappiani A; Mangifesta M; Mancino W; Gueimonde M; Margolles A; van Sinderen D; Ventura M
    Environ Microbiol; 2015 Jul; 17(7):2515-31. PubMed ID: 25523018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in response to environmental gut conditions.
    Turroni F; Serafini F; Mangifesta M; Arioli S; Mora D; van Sinderen D; Ventura M
    FEMS Microbiol Lett; 2014 Aug; 357(1):23-33. PubMed ID: 24947069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers.
    Duranti S; Gaiani F; Mancabelli L; Milani C; Grandi A; Bolchi A; Santoni A; Lugli GA; Ferrario C; Mangifesta M; Viappiani A; Bertoni S; Vivo V; Serafini F; Barbaro MR; Fugazza A; Barbara G; Gioiosa L; Palanza P; Cantoni AM; de'Angelis GL; Barocelli E; de'Angelis N; van Sinderen D; Ventura M; Turroni F
    FEMS Microbiol Ecol; 2016 Dec; 92(12):. PubMed ID: 27604252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifidobacterium bifidum ATCC 15696 and Bifidobacterium breve 24b Metabolic Interaction Based on 2'-
    Centanni M; Ferguson SA; Sims IM; Biswas A; Tannock GW
    Appl Environ Microbiol; 2019 Apr; 85(7):. PubMed ID: 30683741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of sialic acid by Bifidobacterium breve UCC2003.
    Egan M; O'Connell Motherway M; Ventura M; van Sinderen D
    Appl Environ Microbiol; 2014 Jul; 80(14):4414-26. PubMed ID: 24814790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Amino Acid Auxotrophy in Bifidobacterium bifidum PRL2010.
    Ferrario C; Duranti S; Milani C; Mancabelli L; Lugli GA; Turroni F; Mangifesta M; Viappiani A; Ossiprandi MC; van Sinderen D; Ventura M
    Front Microbiol; 2015; 6():1331. PubMed ID: 26635786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging.
    Turroni F; Bottacini F; Foroni E; Mulder I; Kim JH; Zomer A; Sánchez B; Bidossi A; Ferrarini A; Giubellini V; Delledonne M; Henrissat B; Coutinho P; Oggioni M; Fitzgerald GF; Mills D; Margolles A; Kelly D; van Sinderen D; Ventura M
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19514-9. PubMed ID: 20974960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic strategies for mucin metabolism in Bifidobacterium bifidum PRL2010: an example of possible human-microbe co-evolution.
    Turroni F; Milani C; van Sinderen D; Ventura M
    Gut Microbes; 2011; 2(3):183-9. PubMed ID: 21804355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH136-encoding gene (perB) is involved in gut colonization and persistence by Bifidobacterium bifidum PRL2010.
    Rizzo SM; Vergna LM; Alessandri G; Lee C; Fontana F; Lugli GA; Carnevali L; Bianchi MG; Barbetti M; Taurino G; Sgoifo A; Bussolati O; Turroni F; van Sinderen D; Ventura M
    Microb Biotechnol; 2024 Feb; 17(2):e14406. PubMed ID: 38271233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria.
    Bordoni A; Amaretti A; Leonardi A; Boschetti E; Danesi F; Matteuzzi D; Roncaglia L; Raimondi S; Rossi M
    Appl Microbiol Biotechnol; 2013 Sep; 97(18):8273-81. PubMed ID: 23872958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycan cross-feeding activities between bifidobacteria under in vitro conditions.
    Turroni F; Özcan E; Milani C; Mancabelli L; Viappiani A; van Sinderen D; Sela DA; Ventura M
    Front Microbiol; 2015; 6():1030. PubMed ID: 26441950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of intestinal microbiota modulation ability of Bifidobacterium strains in in vitro fecal batch cultures from preterm neonates.
    Arboleya S; Salazar N; Solís G; Fernández N; Hernández-Barranco AM; Cuesta I; Gueimonde M; de los Reyes-Gavilán CG
    Anaerobe; 2013 Feb; 19():9-16. PubMed ID: 23154045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of genetic diversity among strains of the human gut commensal Bifidobacterium adolescentis.
    Duranti S; Milani C; Lugli GA; Mancabelli L; Turroni F; Ferrario C; Mangifesta M; Viappiani A; Sánchez B; Margolles A; van Sinderen D; Ventura M
    Sci Rep; 2016 Apr; 6():23971. PubMed ID: 27035119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifidobacterium longum D2 enhances microbial degradation of long-chain arabinoxylans in an in vitro model of the proximal colon.
    Truchado P; Van den Abbeele P; Rivière A; Possemiers S; De Vuyst L; Van de Wiele T
    Benef Microbes; 2015; 6(6):849-60. PubMed ID: 26193074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.